Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country.
Frederick W ThielenMaite E HouwingMarjon H CnossenIlona A Al Hadithy-IrgiztsevaJan A HazelzetCarin A Uyl-de GrootAnne P J de PagterHedwig M BlommesteinPublished in: Pediatric blood & cancer (2020)
We have described real-world resource use and expenditures for children with sickle cell disease in a European comprehensive care centre. It seems that costs of a comprehensive approach with effective management in the outpatient setting is favourable when compared to episodic health care.